342 related articles for article (PubMed ID: 17520735)
1. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
[TBL] [Abstract][Full Text] [Related]
2. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.
Hosch W; Bock M; Libicher M; Ley S; Hegenbart U; Dengler TJ; Katus HA; Kauczor HU; Kauffmann GW; Kristen AV
Invest Radiol; 2007 Sep; 42(9):636-42. PubMed ID: 17700279
[TBL] [Abstract][Full Text] [Related]
3. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
[TBL] [Abstract][Full Text] [Related]
5. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
Lyne JC; Petryka J; Pennell DJ
Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
[No Abstract] [Full Text] [Related]
6. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.
Sparrow P; Amirabadi A; Sussman MS; Paul N; Merchant N
J Magn Reson Imaging; 2009 Nov; 30(5):942-6. PubMed ID: 19780184
[TBL] [Abstract][Full Text] [Related]
7. [MR imaging in cardiomyopathies].
Miller S; Riessen R
Rofo; 2005 Nov; 177(11):1497-505. PubMed ID: 16302130
[TBL] [Abstract][Full Text] [Related]
8. MR findings in cardiac amyloidosis.
vanden Driesen RI; Slaughter RE; Strugnell WE
AJR Am J Roentgenol; 2006 Jun; 186(6):1682-5. PubMed ID: 16714659
[TBL] [Abstract][Full Text] [Related]
9. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
Roudaut R; Haissaguerre M; Dallocchio M
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1525-31. PubMed ID: 6240237
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance in cardiac amyloidosis.
Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
[TBL] [Abstract][Full Text] [Related]
11. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
[TBL] [Abstract][Full Text] [Related]
12. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement.
Thomson LE
J Am Coll Cardiol; 2008 Mar; 51(10):1031-2. PubMed ID: 18325443
[No Abstract] [Full Text] [Related]
14. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.
Kwong RY; Heydari B; Abbasi S; Steel K; Al-Mallah M; Wu H; Falk RH
Am J Cardiol; 2015 Aug; 116(4):622-9. PubMed ID: 26076990
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
[TBL] [Abstract][Full Text] [Related]
16. [Developmental changes in a case of cardiac amyloidosis: diagnostic value of serious echocardiographic methods].
Iuchi A; Oki S; Uchida T; Kawano T; Hayashi M; Kawano K; Okumoto T; Emi S; Tominaga T; Fukuda N
J Cardiol Suppl; 1989; 22():71-4. PubMed ID: 2640884
[No Abstract] [Full Text] [Related]
17. [MR imaging in cardiac amyloidosis--morphology, function and late enhancement].
Hosch W; Libicher M; Ley S; Heye T; Schnabel P; Dengler TJ; Katus HA; Kauffmann GW; Kauczor HU; Kristen AV
Rofo; 2008 Jul; 180(7):639-45. PubMed ID: 18561066
[TBL] [Abstract][Full Text] [Related]
18. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
Wassmuth R
Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary cardiac amyloidosis with amyloid A protein].
Aouda A; Toyozaki T; Saito T; Yorimitsu K; Miyazaki A; Deguchi F; Inagaki Y
Kokyu To Junkan; 1993 Jan; 41(1):89-92. PubMed ID: 8434166
[TBL] [Abstract][Full Text] [Related]
20. [Chronic heart failure in patients with cardiac amyloidosis].
Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
